- Home
- BVS vs TXO Comparison
BVS vs TXO Comparison
Compare BVS & TXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BVS | TXO |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 783.2M | 720.9M |
| IPO Year | 2016 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BVS | TXO |
|---|---|---|
| Price | $12.45 | $12.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $14.00 | ★ $20.50 |
| AVG Volume (30 Days) | ★ 666.3K | 109.8K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.57% |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $568,087,000.00 | $401,012,000.00 |
| Revenue This Year | $7.52 | $17.21 |
| Revenue Next Year | $7.06 | N/A |
| P/E Ratio | $295.00 | ★ N/A |
| Revenue Growth | N/A | ★ 41.80 |
| 52 Week Low | $5.81 | $10.12 |
| 52 Week High | $12.53 | $15.46 |
Technical Indicators
Market Signals| Indicator | BVS | TXO |
|---|---|---|
| Relative Strength Index (RSI) | 62.84 | 51.44 |
| Support Level | $8.04 | $12.99 |
| Resistance Level | $12.53 | $13.44 |
| Average True Range (ATR) | 0.54 | 0.38 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 80.43 | 48.80 |
Price Performance
Historical ComparisonAbout BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
About TXO TXO Partners L.P.
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America. Its operations focus on enhancing the development and operation of producing properties through its concentration on efficiency and optimizing exploitation of current wells.